|
US3145209A
(en)
|
1961-07-31 |
1964-08-18 |
Olin Mathieson |
Substituted aminophenyl-ethylamine derivatives
|
|
US3975443A
(en)
|
1972-06-06 |
1976-08-17 |
Allen & Hanburys Limited |
1-(3,4-dichlorobenzamidomethyl)-cyclohexyldimethylamine
|
|
DE3718317A1
(de)
|
1986-12-10 |
1988-06-16 |
Bayer Ag |
Substituierte basische 2-aminotetraline
|
|
US5032604A
(en)
|
1989-12-08 |
1991-07-16 |
Merck & Co., Inc. |
Class III antiarrhythmic agents
|
|
DE4302051A1
(de)
|
1993-01-26 |
1994-07-28 |
Thomae Gmbh Dr K |
5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
DE69318854T2
(de)
|
1993-03-04 |
1998-10-08 |
Pfizer |
Spiroazacyclischderivate als substanz p antagonisten
|
|
EP0714299B1
(en)
|
1993-07-16 |
2002-04-24 |
Merck & Co. Inc. |
Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
|
|
US5464788A
(en)
|
1994-03-24 |
1995-11-07 |
Merck & Co., Inc. |
Tocolytic oxytocin receptor antagonists
|
|
CN1157610A
(zh)
|
1994-07-20 |
1997-08-20 |
比克·古尔顿·劳姆贝尔格化学公司 |
抗螺杆菌的吡啶基硫基化合物
|
|
FR2731222A1
(fr)
|
1995-03-02 |
1996-09-06 |
Pf Medicament |
Nouveaux derives de piperazine aminoindoles cycliques, leur procede de preparation et leur utilisation a titre de medicaments
|
|
US5856326A
(en)
|
1995-03-29 |
1999-01-05 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5939418A
(en)
|
1995-12-21 |
1999-08-17 |
The Dupont Merck Pharmaceutical Company |
Isoxazoline, isothiazoline and pyrazoline factor Xa inhibitors
|
|
DE19548624A1
(de)
|
1995-12-23 |
1997-06-26 |
Boehringer Mannheim Gmbh |
Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US6333322B1
(en)
|
1996-03-13 |
2001-12-25 |
Eisai Co., Ltd. |
Nitrogen-containing tricyclic compounds and drugs containing the same
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5885995A
(en)
|
1996-04-03 |
1999-03-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5859012A
(en)
|
1996-04-03 |
1999-01-12 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036591A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JP2000507579A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
|
DE19700431A1
(de)
|
1997-01-10 |
1998-07-16 |
Basf Ag |
Reaktivfarbstoffe mit einem Disulfonylanker
|
|
US6060038A
(en)
|
1997-05-15 |
2000-05-09 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
|
WO1999040075A1
(en)
|
1998-02-05 |
1999-08-12 |
Takeda Chemical Industries, Ltd. |
Sulfonamide derivatives, process for producing the same and utilization thereof
|
|
GB9806287D0
(en)
|
1998-03-24 |
1998-05-20 |
Synphar Lab Inc |
Monobactam enzyme inhibitors
|
|
TWI220143B
(en)
|
1998-05-13 |
2004-08-11 |
Solvay Pharm Gmbh |
Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds and novel cyclic compounds, and intermediate products
|
|
US6380193B1
(en)
|
1998-05-15 |
2002-04-30 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
|
|
AU9298798A
(en)
|
1998-05-15 |
1999-12-06 |
Guilford Pharmaceuticals Inc. |
Fused tricyclic compounds which inhibit parp activity
|
|
US6509338B1
(en)
|
1998-06-22 |
2003-01-21 |
Bristol-Myers Squibb Company |
Pyrazolo[1,5-A]triazine corticotropin releasing factor antagonists
|
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
|
AU3215500A
(en)
|
1999-01-25 |
2000-08-07 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
EP1158983A4
(en)
|
1999-03-03 |
2003-05-21 |
Merck & Co Inc |
Prenyl protein transferase inhibitors
|
|
AU3386600A
(en)
|
1999-03-03 |
2000-09-21 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
AU3248600A
(en)
|
1999-03-03 |
2000-09-21 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferases
|
|
JP2002540072A
(ja)
|
1999-03-03 |
2002-11-26 |
メルク エンド カムパニー インコーポレーテッド |
プレニル蛋白トランスフェラーゼの阻害剤
|
|
EP1165013A4
(en)
|
1999-03-03 |
2002-08-07 |
Merck & Co Inc |
INHIBITORS OF PHENYL PROTEIN TRANSFERASE
|
|
DE19911510A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
AU5464200A
(en)
|
1999-06-09 |
2000-12-28 |
Merck & Co., Inc. |
Biaryl inhibitors of prenyl-protein transferase
|
|
AU5567000A
(en)
|
1999-06-24 |
2001-01-09 |
Toray Industries, Inc. |
Alpha1b-adrenergic receptor antagonists
|
|
AU6936500A
(en)
|
1999-08-24 |
2001-03-19 |
Regents Of The University Of California, The |
Non-quinoline inhibitors of malaria parasites
|
|
DE19944066A1
(de)
|
1999-09-14 |
2001-03-15 |
Byk Gulden Lomberg Chem Fab |
Inhibitoren der Tryptase
|
|
AU7715300A
(en)
|
1999-09-27 |
2001-04-30 |
Merck & Co., Inc. |
Method of preventing osteoporosis
|
|
EP1183259A2
(de)
|
1999-09-28 |
2002-03-06 |
Basf Aktiengesellschaft |
Azepinoindol-derivate, deren herstellung und anwendung
|
|
US20020052380A1
(en)
|
2000-02-18 |
2002-05-02 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
US20020010184A1
(en)
|
2000-02-18 |
2002-01-24 |
Dinsmore Christopher J. |
Inhibitors of prenyl-protein transferase
|
|
WO2001076693A1
(en)
|
2000-04-10 |
2001-10-18 |
Merck & Co., Inc. |
Inhibitors of prenyl-protein transferase
|
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
EP1322643A1
(en)
|
2000-09-29 |
2003-07-02 |
Millennium Pharmaceuticals, Inc. |
Piperazin-2-one amides as inhibitors of factor xa
|
|
US20020124273A1
(en)
|
2000-10-17 |
2002-09-05 |
Jean-Marc Roch |
Protein-protein interactions in neurodegenerative diseases
|
|
CA2433090A1
(en)
|
2000-12-27 |
2002-07-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Dipeptidyl peptidase iv inhibitor
|
|
SE0100902D0
(sv)
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
Compounds
|
|
EP1465867A1
(en)
|
2001-10-09 |
2004-10-13 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
WO2003053941A2
(en)
|
2001-12-20 |
2003-07-03 |
Bristol-Myers Squibb Company |
Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
|
|
AU2002346729A1
(en)
|
2001-12-20 |
2003-07-09 |
Bristol-Myers Squibb Company |
Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
|
|
WO2003061660A1
(en)
|
2002-01-23 |
2003-07-31 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
|
NZ536116A
(en)
|
2002-04-03 |
2007-01-26 |
Topotarget Uk Ltd |
Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors
|
|
US7220735B2
(en)
|
2002-04-18 |
2007-05-22 |
Schering Corporation |
Benzimidazolone histamine H3 antagonists
|
|
US7105505B2
(en)
|
2002-04-18 |
2006-09-12 |
Schering Corporation |
Benzimidazole derivatives useful as histamine H3 antagonists
|
|
WO2003091247A2
(en)
|
2002-04-25 |
2003-11-06 |
Pharmacia Corporation |
Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
US20050209278A1
(en)
|
2002-04-25 |
2005-09-22 |
Mcdonald Joseph J |
Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
|
|
IL165863A0
(en)
|
2002-06-24 |
2006-01-15 |
Schering Corp |
Indole derivatives useful as histamine H3 antagonists
|
|
US6906096B2
(en)
|
2002-06-28 |
2005-06-14 |
Irm Llc |
4,7-Disubstituted indoles and methods of making
|
|
AU2003259131A1
(en)
|
2002-07-09 |
2004-01-23 |
Bristol-Myers Squibb Company |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
|
|
AU2003256922A1
(en)
|
2002-07-31 |
2004-02-16 |
Smithkline Beecham Corporation |
Substituted heterocyclic compounds as modulators of the ccr5 receptor
|
|
EP1542993B1
(en)
|
2002-09-20 |
2012-12-19 |
Merck Serono SA |
Piperazine derivatives and methods of use
|
|
AU2003275632A1
(en)
|
2002-10-25 |
2004-05-13 |
Mitsubishi Pharma Corporation |
N-oxide compounds
|
|
US7452911B2
(en)
|
2002-10-31 |
2008-11-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
WO2004081643A1
(en)
|
2002-12-20 |
2004-09-23 |
Kaiser Aerospace & Electronics Corp. |
Lenslet array with polarization conversion
|
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
|
US20050043533A1
(en)
|
2003-03-25 |
2005-02-24 |
Babiak Kevin A. |
Process for making alpha-substituted hydroxamic acids
|
|
EP1631565A1
(en)
|
2003-05-07 |
2006-03-08 |
Actelion Pharmaceuticals Ltd. |
Piperazine-alkyl-ureido derivatives
|
|
EP1646615B1
(en)
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
ATE551997T1
(de)
*
|
2003-09-12 |
2012-04-15 |
Merck Serono Sa |
Sulfonamid-derivate zur behandlung von diabetes
|
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
|
US20050192286A1
(en)
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
|
GB0328900D0
(en)
|
2003-12-12 |
2004-01-14 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1695961A4
(en)
|
2003-12-17 |
2007-10-24 |
Takeda Pharmaceutical |
UREA DERIVATIVE, METHOD FOR THE PRODUCTION AND THEIR USE
|
|
JP2007515490A
(ja)
|
2003-12-22 |
2007-06-14 |
アムジェン インコーポレーティッド |
アリールスルホンアミド化合物およびそれに関連する使用法
|
|
JP2005232306A
(ja)
|
2004-02-19 |
2005-09-02 |
Fuji Photo Film Co Ltd |
光重合性組成物及びそれを用いた記録材料
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
WO2005087765A1
(en)
|
2004-03-04 |
2005-09-22 |
Arena Pharmaceuticals, Inc. |
Ligands of follicle stimulating hormone receptor and methods of use thereof
|
|
US20050197336A1
(en)
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
|
CA2559285A1
(en)
|
2004-03-18 |
2005-09-29 |
Brigham And Women's Hospital, Inc. |
Methods for the treatment of synucleinopathies
|
|
SE0400850D0
(sv)
|
2004-03-30 |
2004-03-31 |
Astrazeneca Ab |
Novel Compounds
|
|
US7345043B2
(en)
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
|
US20050250789A1
(en)
|
2004-04-20 |
2005-11-10 |
Burns David M |
Hydroxamic acid derivatives as metalloprotease inhibitors
|
|
GB0408777D0
(en)
*
|
2004-04-20 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
ES2346665T3
(es)
|
2004-05-07 |
2010-10-19 |
Warner-Lambert Company Llc |
Derivados de fenol y tiofenol 3- o 4-monosustituidos utiles como ligandos de h3.
|
|
US20090105218A1
(en)
|
2004-05-29 |
2009-04-23 |
7Tm Pharma A/S |
CRTH2 Receptor Ligands For Therapeutic Use
|
|
JP2008501777A
(ja)
|
2004-06-08 |
2008-01-24 |
ファイザー・プロダクツ・インク |
Ｎｋ１拮抗薬として活性なアザビシクロ［３．１．０］ヘキサ−１−イル誘導体
|
|
US20060241118A1
(en)
|
2004-06-18 |
2006-10-26 |
Celltech R&D Limited |
Hydroxamate sulfonamides as cd23 shedding inhibitors
|
|
AU2005262383A1
(en)
|
2004-07-01 |
2006-01-19 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
|
WO2006008644A1
(en)
|
2004-07-13 |
2006-01-26 |
Pfizer Products Inc. |
Antidiabetic compounds
|
|
WO2006012470A1
(en)
|
2004-07-22 |
2006-02-02 |
Cumbre Pharmaceuticals Inc. |
Rifamycin derivatives for treating microbial infections
|
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
|
US20060058311A1
(en)
|
2004-08-14 |
2006-03-16 |
Boehringer Ingelheim International Gmbh |
Combinations for the treatment of diseases involving cell proliferation
|
|
US20060074088A1
(en)
|
2004-08-14 |
2006-04-06 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones for the treatment of cancer diseases
|
|
PE20060653A1
(es)
|
2004-08-31 |
2006-09-27 |
Glaxo Group Ltd |
Derivados triciclicos condensados como moduladores del receptor 5-ht1
|
|
AU2005286790A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase (SCD)
|
|
MX2007003318A
(es)
|
2004-09-20 |
2007-05-18 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como agentes terapeuticos.
|
|
AU2005286647A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
|
US8778874B2
(en)
|
2004-11-29 |
2014-07-15 |
National University Corporation Nagoya University |
Glycopeptide antibiotic monomer derivatives
|
|
PL1828154T3
(pl)
*
|
2004-12-09 |
2009-10-30 |
Hoffmann La Roche |
Pochodne fenylopiperazynometanonu
|
|
PE20061156A1
(es)
|
2004-12-23 |
2006-12-16 |
Glaxo Group Ltd |
Derivados de benzamida como agentes inhibidores del transportador de glicina
|
|
US20100216837A1
(en)
|
2004-12-23 |
2010-08-26 |
Glaxo Group Limited |
Glycine transport inhibitors
|
|
GB0428232D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
PE20061330A1
(es)
|
2004-12-23 |
2006-12-27 |
Glaxo Group Ltd |
Compuestos derivados de benzamida como inhibidores del transportador de glicina
|
|
GB0428233D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Compounds
|
|
WO2006071875A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
WO2006071958A1
(en)
|
2004-12-29 |
2006-07-06 |
Millennium Pharmaceuticals, Inc. |
Compounds useful as chemokine receptor antagonists
|
|
BRPI0519794A2
(pt)
*
|
2005-01-07 |
2009-03-17 |
Hoffmann La Roche |
derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos
|
|
CN101115724A
(zh)
|
2005-02-08 |
2008-01-30 |
默克公司 |
关卡激酶抑制剂
|
|
WO2006102423A1
(en)
|
2005-03-21 |
2006-09-28 |
Celera Genomics |
Alpha ketoamide compounds as cysteine protease inhibitors
|
|
DE102005014936A1
(de)
|
2005-03-24 |
2006-12-14 |
Abbott Gmbh & Co. Kg |
Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
|
|
EP1866298A2
(en)
|
2005-03-31 |
2007-12-19 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
GB0510140D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B2
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
|
CA2610196A1
(en)
|
2005-06-09 |
2006-12-14 |
Merck Frosst Canada Ltd. |
Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
JP2008546695A
(ja)
|
2005-06-13 |
2008-12-25 |
セラヴァンス， インコーポレーテッド |
ムスカリン受容体アンタゴニストとして有用なビフェニル化合物
|
|
TW200738676A
(en)
|
2005-06-20 |
2007-10-16 |
Schering Corp |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
|
|
ATE450525T1
(de)
|
2005-06-20 |
2009-12-15 |
Schering Corp |
Kohlenstoffgebundene substituierte piperidine und derivate daraus als histamin-h3-antagonisten
|
|
US7851474B2
(en)
|
2005-08-02 |
2010-12-14 |
Neurogen Corporation |
Dipiperazinyl ketones and related analogues
|
|
US7834031B2
(en)
*
|
2005-09-29 |
2010-11-16 |
Merck Sharp & Dohme Corp. |
Radiolabeled glycine transporter inhibitors
|
|
JP2009510145A
(ja)
*
|
2005-10-06 |
2009-03-12 |
サノフィ−アベンティス |
環状ｎ−［１，３，４］−チアジアゾール−２−イル−ベンゼンスルホンアミド類、それらの製造方法及び医薬品としてのそれらの使用
|
|
DE102005049954A1
(de)
|
2005-10-19 |
2007-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
|
|
WO2007057742A2
(en)
|
2005-11-18 |
2007-05-24 |
Pfizer Products Inc. |
Novel piperazinone derivatives
|
|
EP1959947A2
(en)
|
2005-12-15 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions and methods
|
|
AU2006331770A1
(en)
|
2005-12-21 |
2007-07-05 |
Schering Corporation |
Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and H3 receptor antagonist/inverse agonist
|
|
US7638531B2
(en)
|
2005-12-21 |
2009-12-29 |
Schering Corporation |
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
|
|
US7879880B2
(en)
|
2005-12-21 |
2011-02-01 |
Schering Corporation |
Substituted aniline derivatives useful as histamine H3 antagonists
|
|
EP1965862A2
(en)
|
2005-12-21 |
2008-09-10 |
Schering Corporation |
Combination of an h3 antagonist/inverse agonist and an appetite suppressant
|
|
BRPI0706365A2
(pt)
|
2006-01-06 |
2011-03-22 |
Sepracor Inc |
Cicloalquilaminas como inibidores da recaptação de monoamina
|
|
GB0600427D0
(en)
|
2006-01-10 |
2006-02-15 |
Glaxo Group Ltd |
Compounds
|
|
KR20080098490A
(ko)
|
2006-01-13 |
2008-11-10 |
파마시클릭스, 인코포레이티드 |
티로신 키나제 억제제 및 이의 용도
|
|
WO2007087220A2
(en)
|
2006-01-25 |
2007-08-02 |
The Trustees Of Columbia University In The City Of New York |
The total synthesis of ecteinascidin 743 and derivatives thereof
|
|
WO2007092435A2
(en)
|
2006-02-07 |
2007-08-16 |
Wyeth |
11-beta hsd1 inhibitors
|
|
KR20080108422A
(ko)
|
2006-02-10 |
2008-12-15 |
얀센 파마슈티카 엔.브이. |
Ｃｘｃｒ3 수용체 길항제로서 피페리딘 유도체
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
CA2648748A1
(en)
|
2006-04-14 |
2007-10-25 |
Takeda Pharmaceutical Company Limited |
Nitrogen-containing heterocyclic compound
|
|
US8017612B2
(en)
|
2006-04-18 |
2011-09-13 |
Japan Tobacco Inc. |
Piperazine compound and use thereof as a HCV polymerase inhibitor
|
|
AU2007284994B2
(en)
|
2006-05-09 |
2010-04-22 |
Merck Sharp & Dohme Corp. |
Substituted spirocyclic CGRP receptor antagonists
|
|
TW200808818A
(en)
|
2006-05-26 |
2008-02-16 |
Shionogi & Co |
Glycopeptide antibiotic derivatives
|
|
WO2007139150A1
(ja)
|
2006-05-30 |
2007-12-06 |
The University Of Tokushima |
ＴＮＦα阻害物質を含有してなる抗インフルエンザウイルス剤
|
|
AU2007256597A1
(en)
|
2006-06-09 |
2007-12-13 |
Icos Corporation |
Substituted phenyl acetic acids as DP-2 antagonists
|
|
GB0612416D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612425D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612437D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612420D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
GB0612435D0
(en)
|
2006-06-22 |
2006-08-02 |
Glaxo Group Ltd |
Compounds
|
|
AU2007265467C1
(en)
|
2006-06-28 |
2013-11-07 |
Amgen Inc. |
Glycine transporter-1 inhibitors
|
|
UA94615C2
(uk)
*
|
2006-06-28 |
2011-05-25 |
Амген Інк. |
Інгібітори транспортера-1 гліцину
|
|
EP2038264B1
(en)
*
|
2006-06-29 |
2016-10-26 |
F.Hoffmann-La Roche Ag |
Tetrazole-substituted arylamides
|
|
JP2008013527A
(ja)
|
2006-07-10 |
2008-01-24 |
Sankyo Co Ltd |
チエノ［３，２−ｄ］ピリミジン−２，４−ジアミン誘導体
|
|
DE102006033114A1
(de)
|
2006-07-18 |
2008-01-24 |
Grünenthal GmbH |
Spirocyclische Azaindol-Derivate
|
|
EP2066318B1
(en)
|
2006-09-21 |
2010-05-12 |
F. Hoffmann-Roche AG |
Oxindole derivatives as anticancer agents
|
|
GB0621607D0
(en)
|
2006-10-31 |
2006-12-06 |
Chroma Therapeutics Ltd |
Inhibitors of c-Met
|
|
EP2079746A2
(en)
|
2006-11-08 |
2009-07-22 |
Schering Corporation |
Imidazopyrazines as protein kinase inhibitors
|
|
CN101528717B
(zh)
*
|
2006-11-09 |
2013-04-24 |
弗·哈夫曼-拉罗切有限公司 |
噻唑和*唑-取代的芳基酰胺类化合物
|
|
US20080153810A1
(en)
|
2006-11-15 |
2008-06-26 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
|
KR20080045537A
(ko)
|
2006-11-20 |
2008-05-23 |
에스케이케미칼주식회사 |
피리딘 화합물을 포함하는 간염 치료 및 예방 또는 간 보호효능을 갖는 약제 조성물
|
|
WO2008066151A1
(fr)
|
2006-11-30 |
2008-06-05 |
Tokyo Institute Of Technology |
Nouveau dérivé curcumine
|
|
AU2007333586A1
(en)
|
2006-12-11 |
2008-06-19 |
Reviva Pharmaceuticals, Inc. |
Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
|
|
US7737149B2
(en)
|
2006-12-21 |
2010-06-15 |
Astrazeneca Ab |
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
|
|
DE102006060598A1
(de)
|
2006-12-21 |
2008-06-26 |
Merck Patent Gmbh |
Tetrahydrobenzoisoxazole
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
JP2010518109A
(ja)
|
2007-02-07 |
2010-05-27 |
ワイス エルエルシー |
ハロゲン化アミンの製造法
|
|
WO2008106479A2
(en)
|
2007-02-27 |
2008-09-04 |
University Of South Florida |
Poly(1,4-piperazin-2-ones) as rod-like protein- protein interaction inhibitors and their production
|
|
CA2679346A1
(en)
|
2007-03-13 |
2008-09-18 |
Biovitrum Ab (Publ) |
Tricyclic isoquinoline derivatives for treatment of obesity
|
|
CA2681162C
(en)
|
2007-03-15 |
2015-11-24 |
Novartis Ag |
Benzyl and pyridine derivatives as modulators of hedgehog pathway
|
|
WO2008122115A1
(en)
|
2007-04-09 |
2008-10-16 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
|
JP2008266236A
(ja)
|
2007-04-23 |
2008-11-06 |
Kyorin Pharmaceut Co Ltd |
環状アミン誘導体又はその塩
|
|
GB0709031D0
(en)
|
2007-05-10 |
2007-06-20 |
Sareum Ltd |
Pharmaceutical compounds
|
|
JP5603770B2
(ja)
|
2007-05-31 |
2014-10-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｃｃｒ２受容体拮抗薬およびその使用
|
|
JP2010208945A
(ja)
|
2007-06-01 |
2010-09-24 |
Mitsubishi Tanabe Pharma Corp |
複素環化合物
|
|
EP2170820A2
(en)
|
2007-06-20 |
2010-04-07 |
Glaxo Group Limited |
Improved process of amide formation
|
|
WO2008157844A1
(en)
*
|
2007-06-21 |
2008-12-24 |
Forest Laboratories Holdings Limited |
Novel piperazine derivatives as inhibitors of stearoyl-coa desaturase
|
|
US20100249144A1
(en)
|
2007-06-28 |
2010-09-30 |
Demong Duane Eugene |
Substituted piperazines as cb1 antagonists
|
|
CA2692268A1
(en)
|
2007-06-28 |
2009-01-08 |
Intervet International B.V. |
Substituted piperazines as cb1 antagonists
|
|
CA2694264A1
(en)
|
2007-06-28 |
2009-01-08 |
Intervet International B.V. |
Substituted piperazines as cb1 antagonists
|
|
WO2009013535A1
(en)
|
2007-07-23 |
2009-01-29 |
Astrazeneca Ab |
2-azabicyclo(2.2.2)octane derivatives as modulators of the glycine transporter i receptor
|
|
JP5160827B2
(ja)
|
2007-07-25 |
2013-03-13 |
塩野義製薬株式会社 |
グリコペプチド抗生物質誘導体
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
WO2010001078A2
(fr)
|
2008-07-04 |
2010-01-07 |
Philippe Marliere |
Production d'alcenes par decarboxylation enzymatique d'acides 3-hydroxy-alcanoïques
|
|
WO2011153359A1
(en)
|
2010-06-04 |
2011-12-08 |
Albany Molecular Research, Inc. |
Glycine transporter-1 inhibitors, methods of making them, and uses thereof
|